centrose is a biotechnology company engaged in the development and commercialization of antibody drug conjugates (ADCs), targeting disease-related cells. It offers extracellular drug conjugate (EDC) technology that produces a new type of ADC that does not require internalization nor degradation. Using antibodies, EDCs precisely place potent drugs within the angstroms of an extracellular target. This way, EDCs reduce off-target toxic side effects and high drug potency because they don’t enter cells and they don’t degrade.